{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T11:32:11Z","timestamp":1777721531002,"version":"3.51.4"},"reference-count":32,"publisher":"IMR Press","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: Transcatheter aortic valve implantation (TAVI) is an established treatment for severe aortic stenosis. The two most widely used platforms are either balloon-expandable intra-annular valve (BEV, Edwards) or self-expanding supra-annular valve (SEV) from Medtronic. Comparative data related to clinical and sub-clinical valve thrombosis are limited. The aim of this study-level meta-analysis is to evaluate its incidence and whether this translates into any difference in clinical outcomes. Methods: Electronic databases were searched from inception through to October 2025 to identify randomised clinical trials of patients receiving either platform. Rates of clinical and subclinical valve thrombosis were identified and compared between the two groups. Results: In five randomized controlled trials including 1877 patients, the risk of clinical and sub-clinical valve thrombosis was relatively low in both groups. There was a significant 81% reduction in clinical valve thrombosis in patients undergoing SEV compared to BEV [0.4% vs. 2.1%; rate ratio (RR) 0.19, 95% confidence interval (CI) (0.04 to 0.86), p = 0.03]. Similarly, the risk of sub-clinical valve thrombosis was significantly lower in the SEV group [0.6% vs. 3.6%; RR 0.22, 95% CI (0.07 to 0.65), p = 0.006]. This difference was not translated into increased risk of stroke, valve re-intervention, or death. Conclusion: Patients undergoing TAVI using SEV compared to BEV have a lower risk of clinical and sub-clinical valve thrombosis in randomized trials, which is largely influenced by small annulus anatomy. Larger studies with longer term follow-up or using a dedicated imaging protocol may provide better insights into the clinical sequelae of this phenomenon.<\/jats:p>","DOI":"10.31083\/rcm48459","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:31:56Z","timestamp":1777458716000},"source":"Crossref","is-referenced-by-count":0,"title":["Supra-Annular Self-Expanding Versus Intra-Annular Balloon-Expandable Transcatheter Aortic Valve Implantation: A Meta-Analysis of Valve-Related Outcomes"],"prefix":"10.31083","volume":"27","author":[{"given":"Mohamed","family":"Ali","sequence":"first","affiliation":[{"name":"Cardiothoracic Centre, Freeman Hospital, NE7 7DN Newcastle-upon-Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trivilou","family":"Paraskevi","sequence":"additional","affiliation":[{"name":"Cardiothoracic Centre, Freeman Hospital, NE7 7DN Newcastle-upon-Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muntaser","family":"Omari","sequence":"additional","affiliation":[{"name":"Cardiothoracic Centre, Freeman Hospital, NE7 7DN Newcastle-upon-Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Farag","sequence":"additional","affiliation":[{"name":"Cardiothoracic Centre, Freeman Hospital, NE7 7DN Newcastle-upon-Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Kuzemczak","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Poznan University of Medical Sciences, 60-806 Poznan, Poland"},{"name":"Department of Internal Diseases and Cardiology, Medical University of Warsaw, 02-005 Warsaw, Poland"},{"name":"Department of Interventional Cardiology and Internal Diseases, Military Institute of Medicine \u2013 National Research Institute, 05-119 Legionowo, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Alkhalil","sequence":"additional","affiliation":[{"name":"Cardiothoracic Centre, Freeman Hospital, NE7 7DN Newcastle-upon-Tyne, UK"},{"name":"Translational and Clinical Research Institute, Newcastle University, NE4 5PL Newcastle-upon-Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Praz F, Lanz J, Adamo M, Borger M. 2025 ESC\/EACTS Guidelines for the management of valvular heart disease. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2025; 67: ezaf393.","DOI":"10.1093\/ejcts\/ezaf393"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Stinis CT, Abbas AE, Teirstein P, Makkar RR, Chung CJ, Iyer V, et al. Real-World Outcomes for the Fifth-Generation Balloon Expandable Transcatheter Heart Valve in the United States. JACC. Cardiovascular Interventions. 2024; 17: 1032\u20131044.","DOI":"10.1016\/j.jcin.2024.02.015"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Gada H, Khalil RF, Chetcuti SJ, Deeb GM, Grubb KJ, Greenbaum AB, et al. 30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum Study. JACC. Cardiovascular Interventions. 2025; 18: 2004\u20132017.","DOI":"10.1016\/j.jcin.2025.06.021"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Worthley SG, Giordano A, Corcione N, Nombela-Franco L, De Marco F, Walton A, et al. 30-Day and 1-Year Outcomes of Navitor Transcatheter Aortic Valve in Low- or Intermediate-Risk Patients. JACC. Cardiovascular Interventions. 2025; 18: 2517\u20132527.","DOI":"10.1016\/j.jcin.2025.08.021"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Antonio Baz J, Burgdorf C, Frerker C, Cruz Gonz\u00e1lez I, Antoni G\u00f4mez J, Graham J, et al. First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIRE I Study. Structural Heart: the Journal of the Heart Team. 2025; 9: 100391.","DOI":"10.1016\/j.shj.2024.100391"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Leon MB, Mack MJ, Pibarot P, Hahn RT, Thourani VH, Kodali SH, et al. Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years. The New England Journal of Medicine. 2025.  (online ahead of print)","DOI":"10.1056\/NEJMoa2509766"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, et al. 5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. Journal of the American College of Cardiology. 2025; 85: 1523\u20131532.","DOI":"10.1016\/j.jacc.2025.03.004"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Herrmann HC, Mehran R, Blackman DJ, Bailey S, M\u00f6llmann H, Abdel-Wahab M, et al. Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus. The New England Journal of Medicine. 2024; 390: 1959\u20131971.","DOI":"10.1056\/NEJMoa2312573"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Omari M, Durrani T, Diaz Nuila ME, Thompson A, Irvine T, Edwards R, et al. Cardiac output in patients with small annuli undergoing transcatheter aortic valve implantation with self-expanding versus balloon expandable valve (COPS-TAVI). Cardiovascular Revascularization Medicine: Including Molecular Interventions. 2025; 73: 15\u201322.","DOI":"10.1016\/j.carrev.2024.06.017"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Abdalwahab A, Omari M, Alkhalil M. Aortic Valve Intervention in Patients with Aortic Stenosis and Small Annulus. Reviews in Cardiovascular Medicine. 2025; 26: 26738.","DOI":"10.31083\/RCM26738"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.). 2021; 372: n71.","DOI":"10.1136\/bmj.n71"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Abdel-Wahab M, Landt M, Neumann FJ, Massberg S, Frerker C, Kurz T, et al. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial. JACC. Cardiovascular Interventions. 2020; 13: 1071\u20131082.","DOI":"10.1016\/j.jcin.2019.12.026"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Nuche J, Abbas AE, Serra V, Vilalta V, Nombela-Franco L, Regueiro A, et al. Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses: 1-Year Results of the LYTEN Trial. JACC. Cardiovascular Interventions. 2023; 16: 2999\u20133012.","DOI":"10.1016\/j.jcin.2023.10.028"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Feistritzer HJ, Kurz T, Vonthein R, Schr\u00f6der L, Stachel G, Eitel I, et al. Effect of Valve Type and Anesthesia Strategy for TAVR: 5-Year Results of the SOLVE-TAVI Trial. Journal of the American College of Cardiology. 2025; 85: 74\u201382.","DOI":"10.1016\/j.jacc.2024.09.007"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Royen NV, Amat-Santos IJ, Hudec M, Bunc M, Ijsselmuiden A, Laanmets P, et al. Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosis. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2025; 21: e105\u2013e118.","DOI":"10.4244\/EIJ-D-24-00951"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Martinsson A, Nielsen SJ, Milojevic M, Redfors B, Omerovic E, T\u00f8nnessen T, et al. Life Expectancy After Surgical Aortic Valve Replacement. Journal of the American College of Cardiology. 2021; 78: 2147\u20132157.","DOI":"10.1016\/j.jacc.2021.09.861"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Foroutan F, Guyatt GH, O\u2019Brien K, Bain E, Stein M, Bhagra S, et al. Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies. BMJ (Clinical Research Ed.). 2016; 354: i5065.","DOI":"10.1136\/bmj.i5065"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"VARC-3 WRITING COMMITTEE, G\u00e9n\u00e9reux P, Piazza N, Alu MC, Nazif T, Hahn RT, et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. European Heart Journal. 2021; 42: 1825\u20131857.","DOI":"10.1093\/eurheartj\/ehaa799"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Hatoum H, Gooden SCM, Sathananthan J, Sellers S, Kutting M, Marx P, et al. Neosinus and Sinus Flow After Self-Expanding and Balloon-Expandable Transcatheter Aortic Valve Replacement. JACC. Cardiovascular Interventions. 2021; 14: 2657\u20132666.","DOI":"10.1016\/j.jcin.2021.09.013"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Makkar RR, Blanke P, Leipsic J, Thourani V, Chakravarty T, Brown D, et al. Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy. Journal of the American College of Cardiology. 2020; 75: 3003\u20133015.","DOI":"10.1016\/j.jacc.2020.04.043"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Chakravarty T, S\u00f8ndergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet (London, England). 2017; 389: 2383\u20132392.","DOI":"10.1016\/S0140-6736(17)30757-2"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Waksman R, Bhogal S, Gordon P, Ehsan A, Wilson SR, Levitt R, et al. Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes. Circulation. Cardiovascular Interventions. 2023; 16: e012655.","DOI":"10.1161\/CIRCINTERVENTIONS.122.012655"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"De Backer O, Dangas GD, Jilaihawi H, Leipsic JA, Terkelsen CJ, Makkar R, et al. Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. The New England Journal of Medicine. 2020; 382: 130\u2013139.","DOI":"10.1056\/NEJMoa1911426"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Marchandot B, Trimaille A, Kikuchi S, Truong DP, Carmona A, Morel O. Subclinical Leaflet Thrombosis and Subclinical Aortic Valve Complex Thrombosis in TAVR. JACC. Advances. 2025; 4: 102085.","DOI":"10.1016\/j.jacadv.2025.102085"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Latib A, Naganuma T, Abdel-Wahab M, Danenberg H, Cota L, Barbanti M, et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circulation. Cardiovascular Interventions. 2015; 8: e001779.","DOI":"10.1161\/CIRCINTERVENTIONS.114.001779"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Blanke P, Leipsic JA, Popma JJ, Yakubov SJ, Deeb GM, Gada H, et al. Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study. Journal of the American College of Cardiology. 2020; 75: 2430\u20132442.","DOI":"10.1016\/j.jacc.2020.03.022"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Hein M, Schoechlin S, Schulz U, Minners J, Breitbart P, Lehane C, et al. Long-Term Follow-Up of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement. JACC. Cardiovascular Interventions. 2022; 15: 1113\u20131122.","DOI":"10.1016\/j.jcin.2022.04.018"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Fujita K, Matsumura K, Sugimoto K, Onishi K, Kakehi K, Yoshida A, et al. Early clinical outcomes of transcatheter aortic valve implantation using the NAVITOR system. Cardiovascular Intervention and Therapeutics. 2025; 40: 378\u2013388.","DOI":"10.1007\/s12928-024-01081-7"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Dangas GD, Tijssen JGP, W\u00f6hrle J, S\u00f8ndergaard L, Gilard M, M\u00f6llmann H, et al. A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. The New England Journal of Medicine. 2020; 382: 120\u2013129.","DOI":"10.1056\/NEJMoa1911425"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Bogyi M, Schernthaner RE, Loewe C, Gager GM, Dizdarevic AM, Kronberger C, et al. Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A Meta-Analysis. JACC. Cardiovascular Interventions. 2021; 14: 2643\u20132656.","DOI":"10.1016\/j.jcin.2021.09.019"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Vahidkhah K, Barakat M, Abbasi M, Javani S, Azadani PN, Tandar A, et al. Valve thrombosis following transcatheter aortic valve replacement: significance of blood stasis on the leaflets. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2017; 51: 927\u2013935.","DOI":"10.1093\/ejcts\/ezw407"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Alkhalil M, Edwards R, Puri R, Kalra A, Zaman A, Das R. Aspirin Versus Dual Antiplatelet Therapy in Patients Undergoing Trans-Catheter Aortic Valve Implantation, Updated Meta-Analysis. Cardiovascular Drugs and Therapy. 2022; 36: 279\u2013283.","DOI":"10.1007\/s10557-021-07146-6"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/4\/10.31083\/RCM48459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:32:27Z","timestamp":1777458747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/4\/10.31083\/RCM48459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1530-6550(26)02684-0"],"URL":"https:\/\/doi.org\/10.31083\/rcm48459","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"48459"}}